Transforming Therapeutic Frontiers: Expert Insights on Novel Epigenomic Biomarkers

Discover how biopharma researchers and clinical oncologists are harnessing the power of novel epigenomic biomarkers to pinpoint the right patients most likely to benefit from your therapy refining your therapeutic strategies and ultimately bringing more effective medicine to the patients who need them.

Speakers:

Ben Herzberg

Assistant Professor, Medicine

Columbia University Irving Medical Center

Steffan Ho

Vice President & Head of Translational Oncology

Pfizer

Justin Odegaard

Senior Vice President, Product Management

Guardant Health

Zoe June Assaf

Senior Director, Cancer Genomics & Emerging Technologies

Revolution Medicines

Jean-Francois Martini

Sr Director, Translational strategy

Guardant Health